Antonijoan, Rosa <br/><br/>
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.  [electronic resource] 

 -  Clinical therapeutics  May 2007 
 - 814-822 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2007.05.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Butyrophenones--adverse effects<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Female<br/>Histamine<br/>Histamine H1 Antagonists--adverse effects<br/>Humans<br/>Loratadine--adverse effects<br/>Male<br/>Pain Measurement<br/>Piperidines--adverse effects<br/>Pruritus--chemically induced<br/>Skin--pathology<br/>Skin Tests